These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 25900184

  • 1. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA, Sands H, Jones L, Clow A, Evans P, Stalder T, Parrott AC.
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [Abstract] [Full Text] [Related]

  • 2. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC, Sands HR, Jones L, Clow A, Evans P, Downey LA, Stalder T.
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
    [Abstract] [Full Text] [Related]

  • 3. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ.
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [Abstract] [Full Text] [Related]

  • 4. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [Abstract] [Full Text] [Related]

  • 5. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
    Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC.
    J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
    [Abstract] [Full Text] [Related]

  • 6. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 7. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

  • 8. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C, Fisk JE.
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [Abstract] [Full Text] [Related]

  • 9. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC, Lasky J.
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [Abstract] [Full Text] [Related]

  • 12. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC, Parrott AC, Turner JJ.
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 15. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 16. MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Parrott AC, Montgomery C, Wetherell MA, Downey LA, Stough C, Scholey AB.
    Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
    [Abstract] [Full Text] [Related]

  • 17. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S, Powell JH.
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [Abstract] [Full Text] [Related]

  • 18. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
    Hanson KL, Luciana M.
    J Clin Exp Neuropsychol; 2010 Apr; 32(4):337-49. PubMed ID: 20397296
    [Abstract] [Full Text] [Related]

  • 19. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD, Vonmoos M, Fürst M, Schädelin K, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB.
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [Abstract] [Full Text] [Related]

  • 20. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.